Conference Coverage

How to beat apremilast-induced diarrhea


 

EXPERT ANALYSIS FROM RWCS 2016

References

He reported serving on scientific advisory boards for, and/or as a consultant to, nine pharmaceutical companies.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Expert examines secukinumab’s role in ankylosing spondylitis treatment strategies
MDedge Rheumatology
Fresh evidence of methotrexate efficacy in psoriatic arthritis
MDedge Rheumatology
Anti-Remicade antibodies also cross-react with infliximab biosimilar
MDedge Rheumatology
New CDC opioid guideline targets overprescribing for chronic pain
MDedge Rheumatology
Sparse, poor evidence supports fumarates for psoriasis
MDedge Rheumatology
ACR’s 2016-2020 research agenda built through consensus
MDedge Rheumatology
Home infusion policies called out in ACR position statement
MDedge Rheumatology
Pushback on Part B drug payment proposal already beginning
MDedge Rheumatology
Ixekizumab approved for plaque psoriasis
MDedge Rheumatology
Genetics, smoking, and inflammation on MRI predict progression in axial SpA
MDedge Rheumatology